Related Experiment Video
Updated: Aug 26, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis
J J Mottet1, F F Horber, J P Casez
1Medizinische Universitätspoliklinik, Inselspital, Berne, Switzerland.
Insights
Continuous ambulatory peritoneal dialysis (CAPD) preserves bone mineral density (BMD), particularly cortical bone, compared to hemodialysis (HD). Higher residual renal function in CAPD patients may contribute to better bone health outcomes.
Area of Science:
- Nephrology
- Bone Metabolism
- Renal Replacement Therapy
Background:
- Dialysis modality's impact on bone mineral density (BMD) remains unclear.
- Comparing continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD) is crucial for patient management.
Purpose of the Study:
- To investigate the specific effects of CAPD versus HD on BMD.
- To identify potential factors influencing BMD differences between dialysis modalities.
Main Methods:
- Dual-energy X-ray absorptiometry (DXA) measured BMD at multiple skeletal sites.
- 34 HD patients and 25 CAPD patients were matched with 125 healthy controls.
- Clinical parameters, renal function, and dialysis characteristics were assessed.
Main Results:
- HD patients showed significantly lower BMD at the femoral neck and tibial epiphysis compared to controls.
- Cortical bone (tibial diaphysis) BMD was significantly lower in HD patients than in CAPD patients and controls.
- CAPD patients exhibited higher residual renal function and similar BMD to controls at most sites.
Conclusions:
- Continuous ambulatory peritoneal dialysis (CAPD) demonstrates a protective effect on cortical bone mineral density compared to hemodialysis (HD).
- Preserved residual renal function in CAPD patients may play a role in maintaining bone health.
- These findings suggest a potential advantage of CAPD for bone health in end-stage renal disease patients.
Abstract:
It is still unclear whether dialysis modality, i.e., continuous ambulatory peritoneal dialysis (CAPD) versus hemodialysis (HD) specifically affects bone mineral density (BMD). To answer this question, 34 patients on HD and 25 on CAPD were matched for age, sex, height, and body weight with 125 normal subjects. BMD was measured using dual-energy X-ray absorptiometry (DXA; Hologic QDR 1000/W) at the lumbar spine (trabecular bone), the femoral neck (mixed cortical and trabecular bone), the distal tibial diaphysis (cortical bone), and the epiphysis (trabecular bone) in all subjects. No significant difference for blood hemoglobin, albumin, total and ionized calcium, intact parathyroid hormone (PTH) or phosphorus concentrations, as well as for alkaline phosphatase activity, failed renal allograft, prior steroid therapy, prior parathyroidectomy, duration of uremia, or of dialysis was found between patients on HD and those on CAPD. However, the residual daily urine volume and renal function at the time of the absorptiometry were higher in CAPD than in HD patients (p < 0.05) as well as the mean dialysate calcium concentration during dialysis, the blood bicarbonate concentration, and the residual renal function at the initiation of dialysis (p < 0.01, p < 0.05, and p < 0.005, respectively). In contrast, the total dose of calcium carbonate was lower in CAPD than in HD patients (p < 0.01). Results of BMD were expressed as Z scores (the number of standard deviations from the appropriate mean of BMD of 623 healthy subjects adjusted for age and sex). At the lumbar spine, no significant difference with respect to BMD was observed between the three groups. At the femoral neck and tibial epiphysis, HD patients had lower BMD (p < 0.001) than normal controls, whereas no difference was observed between HD and CAPD patients. At tibial diaphysis, patients on HD had lower BMD (p < 0.001) than patients on CAPD and than normal controls, with the values being similar in patients on CAPD and in normal controls. The results remained identical after exact matching of HD (n = 25) and CAPD (n = 25) patients for dialysis duration (1.9 +/- 0.3 and 1.7 +/- 0.3 years, respectively). Multiple regression analysis revealed significant negative correlations between Z scores at the lumbar spine (p < 0.05), femoral neck (p < 0.02), tibial diaphysis (p < 0.005), and tibial epiphysis (p < 0.05) on the one hand and plasma alkaline phosphatase activity on the other. The Z score at tibial diaphysis was also correlated with residual renal function at the initiation of dialysis (p < 0.05). In conclusion, this study provides evidence for the preservation of cortical bone with CAPD as opposed to HD. The higher residual renal function observed in the former treatment modality might account, at least in part, for this finding.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Skeleton and Calcium Homeostasis
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

